A Retrospective, Longitudinal Registry Study on the Long-Term Durability of Ivacaftor Treatment in People with Cystic Fibrosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Retrospective, Longitudinal Registry Study on the Long-Term Durability of Ivacaftor Treatment in People with Cystic Fibrosis

Published:2024-09-12 Issue: Volume: Page:
ISSN:2364-1754
Container-title:Pulmonary Therapy
language:en
Short-container-title:Pulm Ther

Author:

Merlo Christian^ORCID,Thorat Teja^ORCID,McGarry Lisa J.^ORCID,Scirica Christina V.,DerSarkissian Maral,Nguyen Catherine,Gu Yuqian M.,Muthukumar Aruna,Healy Joe,Rubin Jaime L.,Brookhart M. Alan

Funder

Vertex Pharmaceuticals

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s41030-024-00269-9.pdf

Reference20 articles.

1. Bell SC, Mall MA, Gutierrez H, et al. The future of cystic fibrosis care: a global perspective. Lancet Respir Med. 2020;8(1):65–124.

2. Corey M, Edwards L, Levison H, et al. Longitudinal analysis of pulmonary function decline in patients with cystic fibrosis. J Pediatr. 1997;131(6):809–14.

3. Konstan MW, Wagener JS, VanDevanter DR. Characterizing aggressiveness and predicting future progression of CF lung disease. J Cyst Fibros. 2009;8 Suppl 1(01):S15–9.

4. Liou TG, Elkin EP, Pasta DJ, et al. Year-to-year changes in lung function in individuals with cystic fibrosis. J Cyst Fibros. 2010;9(4):250–6.

5. Vertex Pharmaceuticals Incorporated. Kalydeco (ivacaftor) [package insert]. 2012.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP